| abstract |
Compounds of formula (I), wherein R @ 1 is as defined in the specification, for the preparation of compounds of formula (I), wherein R @ 1 is as defined in the description, using compounds of formula (I) for treatment of various CNS diseases, for the treatment of neuropsychiatric disorders related to glutamatergic neuropathy system imbalance, CNS ischemic injury, neurodegenerative changes and CNS disorders, affective disorders, depression, PTSD and stress-related diseases, anxiety, schizophrenia and psychotic disorders, pain, addiction, scattered sclerosis, epilepsy, gliomas. The use of compounds of the formula I for the manufacture of a veterinary and human pharmaceutical preparation for the treatment of said diseases as well as the use of the compound for the production of substances used in experimental research, analytical chemistry, food supplement or cosmetic preparation. |